Phathom Pharmaceuticals (PHAT) Non Operating Income: 2022-2025
Historic Non Operating Income for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to -$14.7 million.
- Phathom Pharmaceuticals' Non Operating Income rose 0.53% to -$14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.1 million, marking a year-over-year decrease of 18.55%. This contributed to the annual value of -$56.9 million for FY2024, which is 65.87% down from last year.
- Per Phathom Pharmaceuticals' latest filing, its Non Operating Income stood at -$14.7 million for Q3 2025, which was up 7.45% from -$15.9 million recorded in Q2 2025.
- Over the past 5 years, Phathom Pharmaceuticals' Non Operating Income peaked at -$2.8 million during Q1 2022, and registered a low of -$15.9 million during Q2 2025.
- In the last 3 years, Phathom Pharmaceuticals' Non Operating Income had a median value of -$14.1 million in 2024 and averaged -$12.5 million.
- Examining YoY changes over the last 5 years, Phathom Pharmaceuticals' Non Operating Income showed a top increase of 11.42% in 2023 and a maximum decrease of 180.43% in 2023.
- Over the past 4 years, Phathom Pharmaceuticals' Non Operating Income (Quarterly) stood at -$8.4 million in 2022, then dropped by 15.35% to -$9.7 million in 2023, then tumbled by 55.07% to -$15.0 million in 2024, then rose by 0.53% to -$14.7 million in 2025.
- Its last three reported values are -$14.7 million in Q3 2025, -$15.9 million for Q2 2025, and -$15.5 million during Q1 2025.